JPMorgan Chase & Co’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-69,947
| Closed | -$27K | – | 5150 |
|
|
2020
Q1 | $27K | Sell |
69,947
-66,422
| -49% | -$25.6K | ﹤0.01% | 4297 |
|
|
2019
Q4 | $56K | Sell |
136,369
-28,836
| -17% | -$11.8K | ﹤0.01% | 4205 |
|
|
2019
Q3 | $330K | Buy |
165,205
+1,050
| +0.6% | +$2.1K | ﹤0.01% | 3517 |
|
|
2019
Q2 | $369K | Buy |
164,155
+7
| +0% | +$16 | ﹤0.01% | 3500 |
|
|
2019
Q1 | $519K | Sell |
164,148
-66,433
| -29% | -$210K | ﹤0.01% | 3363 |
|
|
2018
Q4 | $574K | Buy |
230,581
+46,828
| +25% | +$117K | ﹤0.01% | 3320 |
|
|
2018
Q3 | $738K | Buy |
183,753
+12,501
| +7% | +$50.2K | ﹤0.01% | 3315 |
|
|
2018
Q2 | $647K | Buy |
171,252
+1,159
| +0.7% | +$4.38K | ﹤0.01% | 3337 |
|
|
2018
Q1 | $395K | Buy |
170,093
+8,643
| +5% | +$20.1K | ﹤0.01% | 3473 |
|
|
2017
Q4 | $250K | Buy |
161,450
+2,753
| +2% | +$4.26K | ﹤0.01% | 3587 |
|
|
2017
Q3 | $329K | Buy |
158,697
+3,602
| +2% | +$7.47K | ﹤0.01% | 3315 |
|
|
2017
Q2 | $701K | Buy |
155,095
+42,416
| +38% | +$192K | ﹤0.01% | 3041 |
|
|
2017
Q1 | $339K | Buy |
112,679
+57,782
| +105% | +$174K | ﹤0.01% | 3296 |
|
|
2016
Q4 | $151K | Buy |
54,897
+49,691
| +954% | +$137K | ﹤0.01% | 3756 |
|
|
2016
Q3 | $16K | Buy |
5,206
+5,204
| +260,200% | +$16K | ﹤0.01% | 3790 |
|
|
2016
Q2 | $0 | Sell |
2
-600
| -100% | – | ﹤0.01% | 4435 |
|
|
2016
Q1 | $2K | Buy |
602
+600
| +30,000% | +$1.99K | ﹤0.01% | 4033 |
|
|
2015
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4168 |
|